首页> 外文期刊>Current HIV Research >Risk Factors, CD4 Long-Term Evolution and Mortality of HIV-Infected Patients who Persistently Maintain Low CD4 Counts, Despite Virological Response to HAART
【24h】

Risk Factors, CD4 Long-Term Evolution and Mortality of HIV-Infected Patients who Persistently Maintain Low CD4 Counts, Despite Virological Response to HAART

机译:尽管对HAART进行了病毒学应答,但仍保持CD4计数低的HIV感染患者的危险因素,CD4长期演变和死亡率

获取原文
获取原文并翻译 | 示例
           

摘要

A proportion of HIV-patients does not normally restore their CD4 counts despite virological response to HAART. Those whose CD4 counts persistently remain closed to the critical threshold for opportunistic infections deserve special interest. To study the risk factors, the long-term CD4 counts evolution, and the risk of death of patients who persistently maintain low CD4 counts, despite virological response to HAART, within a multicenter, hospital-based cohort study. A total of 147 patients were selected from CoRIS-MD and classified into a “Low-Group” or a “High- Group”, depending on their CD4 counts after two-years of effective HAART (threshold 250 cells/μL). Associated risk factors were analysed by logistic regression, the CD4 dynamics were evaluated over a total period of 7.70 years (IQR, 6.70-9.00), and mortality was estimated by Cox proportional hazard. A total of 40 patients (27%) were classified into the “Low-Group”. The odds ratio for this group increased with age, being 4.56 (2.23-9.33) for over 40, and was also higher among IDU, 3.63 (1.04-12.68). Six years thereafter, among these patients, only a 30% exceeded 350 CD4 cells/μL and a 12% exceeded 500 CD4 cells/μL. Furthermore, the “Low-Group” had a death rate of 2.42 per 100 persons/year (95%CI, 1.01-5.81), although once adjusted by age the estimates were no longer significant [4.14 (0.87-19.72)]. Our results suggest that those HIV patients who have not overcome the critical threshold of 250 CD4 cells/μL after a two years period of virologically effective HAART do persist with the aforementioned failure of CD4 restoration for a much longer time.
机译:尽管对HAART进行了病毒学应答,但仍有一部分HIV患者通常无法恢复其CD4计数。那些CD4计数持续保持接近机会性感染临界阈值的人群值得特别关注。为了研究危险因素,在一项基于医院的多中心队列研究中,尽管对HAART进行了病毒学应答,但长期CD4计数的演变以及长期维持CD4计数低的患者的死亡风险。从CoRIS-MD中总共选择了147名患者,根据有效HAART两年(阈值250细胞/μL)后的CD4计数,将其分为“低组”或“高组”。通过logistic回归分析相关的危险因素,在总的7.70年内评估CD4动力学(IQR,6.70-9.00),并通过Cox比例风险评估死亡率。共有40例患者(27%)被归类为“低组”。该组的优势比随年龄增长而增加,40岁以上的优势比为4.56(2.23-9.33),IDU的优势比也更高,为3.63(1.04-12.68)。此后六年,在这些患者中,只有30%的患者超过350个CD4细胞/μL,而12%的患者超过500个CD4细胞/μL。此外,“低级群体”的死亡率为每100人/年2.42(95%CI,1.01-5.81),尽管一旦按年龄进行调整,估计值就不再有意义[4.14(0.87-19.72)]。我们的结果表明,经过两年的病毒学有效的HAART治疗后,仍未超过250 CD4细胞/μL临界阈值的HIV患者仍会因上述CD4恢复失败而持续更长的时间。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号